Skip to main content
Thorax logoLink to Thorax
. 2000 Mar;55(3):232–234. doi: 10.1136/thorax.55.3.232

Non-invasive markers of airway inflammation as predictors of oral steroid responsiveness in asthma

S Little 1, G Chalmers 1, K MacLeod 1, C McSharry 1, N Thomson 1
PMCID: PMC1745700  PMID: 10679543

Abstract

BACKGROUND—Sputum eosinophil counts and exhaled nitric oxide (NO) levels are increased in asthma and both measurements fall in response to corticosteroids.
METHODS—Exhaled NO levels and sputum eosinophil counts were assessed as non-invasive markers of the response to an oral steroid in 37 patients (19 women) with stable chronic asthma (mean (SD) age 48.6 (12.2) years, asthma duration 25.9 (17.3) years, and baseline forced expiratory volume in one second (FEV1) 76.3 (21.9)% predicted). Spirometric tests, with reversibility to a β agonist (2.5 mg nebulised salbutamol), and induced sputum (using nebulised 3% saline) were performed at recruitment and following treatment with 30 mg prednisolone/day for 14days.
RESULTS—Baseline NO levels correlated with the percentage improvement in FEV1 from baseline to the post-steroid, post-bronchodilator value (rs = 0.47, p = 0.003), with an NO level of >10 ppb at baseline having a positive predictive value of 83% for an improvement in FEV1 of ⩾15% (sensitivity 59%, specificity 90%). Sputum eosinophilia (⩾4%) had a positive predictive value of 68% (sensitivity 54%, specificity 76%) for an increase in FEV1 of ⩾15%. A combination of sputum eosinophilia and increased NO levels resulted in a positive predictive value of 72% and a negative predictive value of 79% (sensitivity 76%, specificity 75%).
CONCLUSION—Exhaled NO levels and sputum eosinophilia may be useful in predicting the response to a trial of oral steroid in asthma.



Full Text

The Full Text of this article is available as a PDF (110.8 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Fabbri L. M., Caramori G., Beghé B., Papi A., Ciaccia A. Physiologic consequences of long-term inflammation. Am J Respir Crit Care Med. 1998 May;157(5 Pt 2):S195–S198. doi: 10.1164/ajrccm.157.5.rsaa-6. [DOI] [PubMed] [Google Scholar]
  2. Hargreave F. E., Ryan G., Thomson N. C., O'Byrne P. M., Latimer K., Juniper E. F., Dolovich J. Bronchial responsiveness to histamine or methacholine in asthma: measurement and clinical significance. J Allergy Clin Immunol. 1981 Nov;68(5):347–355. doi: 10.1016/0091-6749(81)90132-9. [DOI] [PubMed] [Google Scholar]
  3. Kharitonov S. A., Yates D. H., Barnes P. J. Inhaled glucocorticoids decrease nitric oxide in exhaled air of asthmatic patients. Am J Respir Crit Care Med. 1996 Jan;153(1):454–457. doi: 10.1164/ajrccm.153.1.8542158. [DOI] [PubMed] [Google Scholar]
  4. Kharitonov S. A., Yates D., Robbins R. A., Logan-Sinclair R., Shinebourne E. A., Barnes P. J. Increased nitric oxide in exhaled air of asthmatic patients. Lancet. 1994 Jan 15;343(8890):133–135. doi: 10.1016/s0140-6736(94)90931-8. [DOI] [PubMed] [Google Scholar]
  5. Kharitonov S., Alving K., Barnes P. J. Exhaled and nasal nitric oxide measurements: recommendations. The European Respiratory Society Task Force. Eur Respir J. 1997 Jul;10(7):1683–1693. doi: 10.1183/09031936.97.10071683. [DOI] [PubMed] [Google Scholar]
  6. Pavord I. D., Brightling C. E., Woltmann G., Wardlaw A. J. Non-eosinophilic corticosteroid unresponsive asthma. Lancet. 1999 Jun 26;353(9171):2213–2214. doi: 10.1016/S0140-6736(99)01813-9. [DOI] [PubMed] [Google Scholar]
  7. Pin I., Gibson P. G., Kolendowicz R., Girgis-Gabardo A., Denburg J. A., Hargreave F. E., Dolovich J. Use of induced sputum cell counts to investigate airway inflammation in asthma. Thorax. 1992 Jan;47(1):25–29. doi: 10.1136/thx.47.1.25. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Popov T., Gottschalk R., Kolendowicz R., Dolovich J., Powers P., Hargreave F. E. The evaluation of a cell dispersion method of sputum examination. Clin Exp Allergy. 1994 Aug;24(8):778–783. doi: 10.1111/j.1365-2222.1994.tb00990.x. [DOI] [PubMed] [Google Scholar]
  9. Turner M. O., Hussack P., Sears M. R., Dolovich J., Hargreave F. E. Exacerbations of asthma without sputum eosinophilia. Thorax. 1995 Oct;50(10):1057–1061. doi: 10.1136/thx.50.10.1057. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Vignola A. M., Chanez P., Campbell A. M., Souques F., Lebel B., Enander I., Bousquet J. Airway inflammation in mild intermittent and in persistent asthma. Am J Respir Crit Care Med. 1998 Feb;157(2):403–409. doi: 10.1164/ajrccm.157.2.96-08040. [DOI] [PubMed] [Google Scholar]

Articles from Thorax are provided here courtesy of BMJ Publishing Group

RESOURCES